BD Hypak™ for Biotech Glass Prefillable Syringe
Select a syringe adapted for biotech drugs
- Overview
- Products & Accessories
- Resources
The BD Hypak™ for Biotech Glass Prefillable Syringe is our versatile prefillable syringe delivery system that addresses key factors of compatibility with biopharmaceutical drugs.
Design for biotech drugs and chronic treatment
The BD Hypak™ for Biotech Glass Prefillable Syringe platform has been specifically optimized for use with biopharmaceuticals. This comprises improved container/drug compatibility, container/device compatibility and cosmetic quality.1,2
Drug compatibility
The BD Hypak™ for Biotech Glass Prefillable Syringe is equipped with low tungsten residue levels and available with highly pure elastomer components, reducing potential risks of drug/container incompatibility.1,2
Device compatibility
The BD Hypak™ for Biotech Glass Prefillable Syringe has been optimized to assure compatibility with secondary devices, such as autoinjectors. It features specification of key interface dimensions, increased flange resistance and siliconization regimes optimized for autoinjector-facilitated drug delivery.4
Cosmetic quality
The BD Hypak™ for Biotech Glass Prefillable Syringe features an improved level of cosmetic quality. This is intended to help reduce breakage and remove rates of false rejects during final inspection. In addition, it helps make the syringe more breakage resistant.5
- Tungsten quantification between Hypak, Hypak for biotech and Neopak [internal study]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2017.
- Silicone quality and silicone profile (Hypak for biotech and Neopak) [internal study]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2013.
- Key biologics in BD syringes [internal study]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2017.
- Cosmetic defects and glass resistance comparison between Hypak, Hypak for biotech and Neopak [internal study]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2017.
- Neopak vs. Hypak for biotech specification comparison [internal study]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2017.
